< Back to previous page
Researcher
Peter Witters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Woman and Child (Division)
Member
From1 Oct 2014 → Today - Hepatology (Division)
Member
From1 Oct 2006 → 30 Sep 2010
Projects
1 - 10 of 11
- Reconstruction and Computational Modelling for Inherited Metabolic DiseasesFrom1 Jun 2023 → TodayFunding: HORIZON.2.1 - Health
- A novel hybrid metabolomics platform combining the power of gas chromatography separation with highresolution, high-accuracy mass spectrometry of full precursor masses.From1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Towards treatments of Congenital Disorders of GlycosylationFrom1 Oct 2021 → TodayFunding: FWO fundamental clinical research fellowship
- Metabolomics as a tool for developing therapies in an endothelial cell model of congenital disorders of glycosylationFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The endothelium is a central mediator of cystic fibrosis lung diseaseFrom20 Nov 2020 → 24 May 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Studying congenital disorders of glycosylation and their potential treatments using tracer metabolomicsFrom24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Vascular & immune microenvironments in patients with CF-associated liver disease.From3 Sep 2020 → 31 Aug 2023Funding: Other federal public and semi-governmental institutions
- Galactose rewires metabolism in the treatment of congenital disorders of glycosylation.From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Mapping and treating metabolic rewiring in mitochondrial diseaseFrom1 Oct 2018 → 13 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- DE ROL VAN HET ENDOTHEEL IN MUCOVISCIDOSE GEASSOCIEERDE LEVERZIEKTEFrom1 Dec 2017 → 24 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 94
- Glycosphingolipids in congenital disorders of glycosylation (CDG).(2024)
Authors: Andrea Jáñez Pedrayes, Daisy Rymen, Bart Ghesquière, Peter Witters
Pages: 108434 - Tracer metabolomics reveals the role of aldose reductase in glycosylation(2023)
Authors: Karen Driesen, Pieter Vermeersch, David Cassiman, Peter Witters
- Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results (vol 17, 437, 2022)(2023)
Authors: Peter Witters
- Fractionated plasma N-glycan profiling of novel cohort of ATP6AP1-CDG subjects identifies phenotypic association(2023)
Authors: Peter Witters
Pages: 300 - 312 - Long-term catch-up growth in children with acid sphingomyelinase deficiency treated with olipudase adlfa enzyme replacement therapy in the ASCEND-Peds trial(2023)
Authors: Peter Witters
Pages: 48 - 48 - Mapping and treating metabolic rewiring in mitochondrial disease(2023)
Authors: Isabelle Adant, David Cassiman, Pieter Vermeersch, Peter Witters, Bart Ghesquière
- Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results(2022)
Authors: Peter Witters
- Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction(2022)
Authors: Isabelle Adant, Bram Decru, Peter de Witte, Peter Witters, Pieter Vermeersch, David Cassiman
- Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature(2022)
Authors: Ilse Hoffman, Noël Knops, Peter Witters, Marijke Proesmans
- Understanding Inborn Errors of Metabolism through Metabolomics(2022)
Authors: Karen Driesen, Peter Witters